Zevra Therapeutics Inc (NASDAQ:ZVRA) currently has a daily average trading volume of 784.84K but it saw 1494018 shares traded in last market. With a market cap of 692.24M USD, the company’s current market price of $12.66 came rising about 2.76 while comparing to the previous closing price of $12.32. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.16 and as low as $5.45. In the recent trading on the day, stock has struck highest price mark of $12.205 while lowest mark touched by it was $12.75.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on July 02, 2025, recommending a price target of $26 for it. Guggenheim also issued its recommendations for the stock as it initiated the price target for the stock is $20.
Over the week, ZVRA’s stock price is moving 5.32% up while it is 38.74% when we observe its performance for the past one month. Year-to-date it is 116.41% up and over the past year, the stock is showing an upside performance of 51.80%.
Currently, Zevra Therapeutics Inc’s total number of outstanding shares is 54.68M. Company’s return on investment (ROI) stands at -89.95% and return on equity (ROE) at -204.78%. It has a 20.06 of forward P/E ratio. Stock’s beta reads 1.84. Stock has a price to book (P/B) ratio of 16.87 while price to sale or P/S ratio amounts to 17.05. Its return on asset (ROA) is -56.78% on average.
